Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

  1. Fust, K.
  2. Li, X.
  3. Maschio, M.
  4. Villa, G.
  5. Parthan, A.
  6. Barron, R.
  7. Weinstein, M.C.
  8. Somers, L.
  9. Hoefkens, C.
  10. Lyman, G.H.
Revue:
PharmacoEconomics

ISSN: 1179-2027,  1170-7690

Année de publication: 2017

Volumen: 35

Número: 4

Pages: 425-438

Type: Article

DOI: 10.1007/S40273-016-0474-0 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus